Novel immunotherapies.

@article{Yi2009NovelI,
  title={Novel immunotherapies.},
  author={Qing Yi},
  journal={Cancer journal},
  year={2009},
  volume={15 6},
  pages={502-10}
}
Multiple myeloma is still a fatal disease. Despite advances in high-dose chemotherapy and stem-cell transplantation and the development of novel therapeutics, relapse of the underlying disease remains the primary cause of treatment failure. Strategies for posttransplantation immunomodulation are desirable for eradication of remaining tumor cells. To this end, immunotherapy aimed at inducing myeloma-specific immunity in patients has been explored. Idiotype protein, secreted by myeloma cells, has… CONTINUE READING